Cellevate develops and markets products based on a proprietary nanofiber-based platform - the Cellevat3d™ - with the potential to revolutionize upstream bioprocessing from R&D to commercial manufacturing. Our latest product line in development – Cellevat3d™ carriers – with a commercial launch planned for 2024, provides extracellular-like environments with exceptional surface areas for adherent cell cultures. Initial results show tremendous potential to increase yields, minimize risk and reduce costs in development and manufacturing.

We offer a range of products based on our versatile and easily functionalized platform for several applications, including next generation cell- and gene therapies.

For more information, please visit www.cellevate.com


Biotechnology

Manufacturing

Nanotechnology

Pharmaceutical

Cellevate AB

Laura Chirica

Jean - Christophe Bourdon

Raul Izquierdo

Nils Uhlin

Linda Dexlin Mellby

Maximilian Ottosson

Alexander Dahlquist

Albin Jakobsson

The Leadership Team at Cellevate AB is responsible for steering the company's strategic direction, overseeing the development and commercialization of innovative products based on the Cellevat3d™ platform. This includes aligning R&D efforts, financial planning, business development, and operational management to ensure the successful launch and market uptake of products aimed at revolutionizing bioprocessing and enhancing cell- and gene therapies.

Leadership Team

Sales and Marketing

Leadership Team

About

Team members

Other teams at Cellevate AB

Sales and Marketing